HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $7.46 billion. The enterprise value is $8.19 billion.
| Market Cap | 7.46B |
| Enterprise Value | 8.19B |
Important Dates
The last earnings date was Monday, June 3, 2024, after market close.
| Earnings Date | Jun 3, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 87.01 million shares outstanding. The number of shares has increased by 2.58% in one year.
| Shares Outstanding | 87.01M |
| Shares Change (YoY) | +2.58% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 2.05% |
| Owned by Institutions (%) | 101.23% |
| Float | 85.53M |
Valuation Ratios
The trailing PE ratio is 93.22 and the forward PE ratio is 29.60. HealthEquity's PEG ratio is 2.29.
| PE Ratio | 93.22 |
| Forward PE | 29.60 |
| PS Ratio | 7.16 |
| Forward PS | 6.36 |
| PB Ratio | 3.56 |
| P/FCF Ratio | 32.56 |
| PEG Ratio | 2.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.00, with an EV/FCF ratio of 35.75.
| EV / Earnings | 101.88 |
| EV / Sales | 7.86 |
| EV / EBITDA | 27.00 |
| EV / EBIT | 54.44 |
| EV / FCF | 35.75 |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.47.
| Current Ratio | 4.39 |
| Quick Ratio | 3.88 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 3.24 |
| Debt / FCF | 4.29 |
| Interest Coverage | 2.88 |
Financial Efficiency
Return on equity (ROE) is 4.00% and return on invested capital (ROIC) is 3.62%.
| Return on Equity (ROE) | 4.00% |
| Return on Assets (ROA) | 2.60% |
| Return on Capital (ROIC) | 3.62% |
| Revenue Per Employee | $331,032 |
| Profits Per Employee | $25,534 |
| Employee Count | 3,150 |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $17.84 million in taxes.
| Income Tax | 17.84M |
| Effective Tax Rate | 18.15% |
Stock Price Statistics
The stock price has increased by +37.46% in the last 52 weeks. The beta is 0.55, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +37.46% |
| 50-Day Moving Average | 81.20 |
| 200-Day Moving Average | 75.94 |
| Relative Strength Index (RSI) | 59.25 |
| Average Volume (20 Days) | 667,050 |
Short Selling Information
The latest short interest is 3.28 million, so 3.77% of the outstanding shares have been sold short.
| Short Interest | 3.28M |
| Short Previous Month | 3.04M |
| Short % of Shares Out | 3.77% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 4.91 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.04 billion and earned $80.43 million in profits. Earnings per share was $0.92.
| Revenue | 1.04B |
| Gross Profit | 661.95M |
| Operating Income | 136.15M |
| Pretax Income | 98.27M |
| Net Income | 80.43M |
| EBITDA | 303.50M |
| EBIT | 150.52M |
| Earnings Per Share (EPS) | $0.92 |
Balance Sheet
The company has $251.23 million in cash and $983.68 million in debt, giving a net cash position of -$732.45 million or -$8.42 per share.
| Cash & Cash Equivalents | 251.23M |
| Total Debt | 983.68M |
| Net Cash | -732.45M |
| Net Cash Per Share | -$8.42 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 24.11 |
| Working Capital | 312.69M |
Cash Flow
In the last 12 months, operating cash flow was $276.72 million and capital expenditures -$47.51 million, giving a free cash flow of $229.21 million.
| Operating Cash Flow | 276.72M |
| Capital Expenditures | -47.51M |
| Free Cash Flow | 229.21M |
| FCF Per Share | $2.65 |
Margins
Gross margin is 63.48%, with operating and profit margins of 13.06% and 7.71%.
| Gross Margin | 63.48% |
| Operating Margin | 13.06% |
| Pretax Margin | 9.42% |
| Profit Margin | 7.71% |
| EBITDA Margin | 29.11% |
| EBIT Margin | 14.43% |
| FCF Margin | 21.98% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.58% |
| Shareholder Yield | -2.58% |
| Earnings Yield | 1.08% |
| FCF Yield | 3.07% |
Analyst Forecast
The average price target for HealthEquity is $101.45, which is 18.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $101.45 |
| Price Target Difference | 18.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.59 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.59 |
| Piotroski F-Score | 7 |